Mendell JR, Al-Zaidy S, Shell R, Arnold WD, Rodino-Klapac LR, Prior TW, et al. Single-dose gene-replacement therapy for spinal muscular atrophy. N Engl J Med. 2017;377:1713–22.

Article  CAS  PubMed  Google Scholar 

Nathwani AC, Reiss UM, Tuddenham EGD, Rosales C, Chowdary P, McIntosh J, et al. Long-term safety and efficacy of factor IX gene therapy in hemophilia B. N Engl J Med. 2014;371:1994–2004.

Article  PubMed  PubMed Central  Google Scholar 

Wang JH, Gessler DJ, Zhan W, Gallagher TL, Gao G. Adeno-associated virus as a delivery vector for gene therapy of human diseases. Signal Transduct Target Ther. 2024;9:1–33.

Google Scholar 

Boutin S, Monteilhet V, Veron P, Leborgne C, Benveniste O, Montus MF, et al. Prevalence of serum IgG and neutralizing factors against adeno-associated virus (AAV) types 1, 2, 5, 6, 8, and 9 in the healthy population: implications for gene therapy using AAV vectors. Hum Gene Ther. 2010;21:704–12.

Article  CAS  PubMed  Google Scholar 

Calcedo R, Wilson JM. Humoral immune response to AAV. Front Immunol [Internet]. 2013 [cited 2025 Mar 20];4. Available from: https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2013.00341/full.

Dhungel BP, Winburn I, Pereira CdaF, Huang K, Chhabra A, Rasko JEJ. Understanding AAV vector immunogenicity: from particle to patient. Theranostics. 2024;14:1260–88.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bartel M, Schaffer D, Büning H. Enhancing the clinical potential of AAV vectors by capsid engineering to evade pre-existing immunity. Front Microbiol. 2011;2:204.

Article  PubMed  PubMed Central  Google Scholar 

Chan YK, Wang SK, Chu CJ, Copland DA, Letizia AJ, Costa Verdera H, et al. Engineering adeno-associated viral vectors to evade innate immune and inflammatory responses. Sci Transl Med. 2021;13:eabd3438.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cheng M, Dietz L, Gong Y, Eichler F, Nammour J, Ng C, et al. Neutralizing antibody evasion and transduction with purified extracellular vesicle-enveloped adeno-associated virus vectors. Hum Gene Ther. 2021;32:1457–70.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Elmore ZC, Oh DK, Simon KE, Fanous MM, Asokan A. Rescuing AAV gene transfer from neutralizing antibodies with an IgG-degrading enzyme. JCI Insight. 2020;5:e139881.

György B, Fitzpatrick Z, Crommentuijn MH, Mu D, Maguire CA. Naturally enveloped AAV vectors for shielding neutralizing antibodies and robust gene delivery in vivo. Biomaterials. 2014;35:7598–609.

Article  PubMed  PubMed Central  Google Scholar 

Leborgne C, Barbon E, Alexander JM, Hanby H, Delignat S, Cohen DM, et al. IgG-cleaving endopeptidase enables in vivo gene therapy in the presence of anti-AAV neutralizing antibodies. Nat Med. 2020;26:1096–101.

Article  CAS  PubMed  Google Scholar 

Li X, La Salvia S, Liang Y, Adamiak M, Kohlbrenner E, Jeong D, et al. Extracellular vesicle–encapsulated adeno-associated viruses for therapeutic gene delivery to the heart. Circulation. 2023;148:405–25.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li X, Wei X, Lin J, Ou L. A versatile toolkit for overcoming AAV immunity. Front Immunol [Internet]. 2022 [cited 2025 Mar 20];13. Available from: https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2022.991832/full.

Mingozzi F, High KA. Immune responses to AAV vectors: overcoming barriers to successful gene therapy. Blood. 2013;122:23–36.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ros-Gañán I, Hommel M, Trigueros-Motos L, Tamarit B, Rodríguez-García E, Salas D, et al. Optimising the IgG-degrading enzyme treatment regimen for enhanced adeno-associated virus transduction in the presence of neutralising antibodies. Clin Transl Immunol. 2022;11:e1375.

Article  Google Scholar 

Vrellaku B, Sethw Hassan I, Howitt R, Webster CP, Harriss E, McBlane F, et al. A systematic review of immunosuppressive protocols used in AAV gene therapy for monogenic disorders. Mol Ther. 2024;32:3220–59.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Baatartsogt N, Kashiwakura Y, Hayakawa M, Kamoshita N, Hiramoto T, Mizukami H, et al. A sensitive and reproducible cell-based assay via secNanoLuc to detect neutralizing antibody against adeno-associated virus vector capsid. Mol Ther Methods Clin Dev. 2021;22:162–71.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kashiwakura Y, Baatartsogt N, Yamazaki S, Nagao A, Amano K, Suzuki N, et al. The seroprevalence of neutralizing antibodies against the adeno-associated virus capsids in Japanese hemophiliacs. Mol Ther Methods Clin Dev. 2022;27:404–14.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pan Y, Rohde M, Zeitler J, Namburi SVS, Cao L, Hu J, et al. A sensitive AAV transduction inhibition assay assists evaluation of critical factors for detection and concordance of pre-existing antibodies. Mol Ther - Methods Clin Dev. 2023;31:101126.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rogers GL, Huang C, Clark RDE, Seclén E, Chen HY, Cannon PM. Optimization of AAV6 transduction enhances site-specific genome editing of primary human lymphocytes. Mol Ther Methods Clin Dev. 2021;23:198–209.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang M, Sun J, Crosby A, Woodard K, Hirsch ML, Samulski RJ, et al. Direct interaction of human serum proteins with AAV virions to enhance AAV transduction: immediate impact on clinical applications. Gene Ther. 2017;24:49–59.

Article  CAS  PubMed  Google Scholar 

Adachi K, Dissen GA, Lomniczi A, Xie Q, Ojeda SR, Nakai H. Adeno-associated virus-binding antibodies detected in cats living in the Northeastern United States lack neutralizing activity. Sci Rep. 2020;10:10073.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Desrosiers M, Dalkara D. Neutralizing antibodies against adeno-associated virus (AAV): measurement and influence on retinal gene delivery. In: Boon CJF, Wijnholds J, editors. Retinal gene therapy [Internet]. Methods in Molecular Biology; vol. 1715. New York, NY: Springer New York; 2018 [cited 2025 Jan 2]. pp. 225–38. Available from: http://link.springer.com/10.1007/978-1-4939-7522-8_16.

Jungmann A, Müller O, Rapti K. Cell-based measurement of neutralizing antibodies against adeno-associated virus (AAV). Methods Mol Biol. 2017;1521:109–26.

Article  CAS  PubMed  Google Scholar 

Rapti K, Louis-Jeune V, Kohlbrenner E, Ishikawa K, Ladage D, Zolotukhin S, et al. Neutralizing antibodies against AAV serotypes 1, 2, 6, and 9 in sera of commonly used animal models. Mol Ther. 2012;20:73–83.

Article  CAS  PubMed  Google Scholar 

Wang L, Calcedo R, Bell P, Lin J, Grant RL, Siegel DL, et al. Impact of Pre-existing immunity on gene transfer to nonhuman primate liver with adeno-associated virus 8 vectors. Hum Gene Ther. 2011;22:1389.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hu X, An T, Situ B, Hu Y, Ou Z, Li Q, et al. Heat inactivation of serum interferes with the immunoanalysis of antibodies to SARS-CoV-2. J Clin Lab Anal. 2020;34:e23411.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Schulz M, Levy DI, Petropoulos CJ, Bashirians G, Winburn I, Mahn M, et al. Binding and neutralizing anti-AAV antibodies: detection and implications for rAAV-mediated gene therapy. Mol Ther. 2023;31:616–30.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yang TY, Braun M, Lembke W, McBlane F, Kamerud J, DeWall S, et al. Immunogenicity assessment of AAV-based gene therapies: an IQ consortium industry white paper. Mol Ther Methods Clin Dev. 2022;26:471–94.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kovács B, Somogyi F, Szabó V, Nagy ZZ, Hernadi I, Matyas F, et al. CoreTIA: a modular, statistically robust transduction inhibition assay for AAV neutralization. Front Immunol [Internet]. 2025 [cited 2025 July 30];16. Available from: https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2025.1623848/full.

Goertsen D, Flytzanis NC, Goeden N, Chuapoco MR, Cummins A, Chen Y, et al. AAV capsid variants with brain-wide transgene expression and decreased liver targeting after intravenous delivery in mouse and marmoset. Nat Neurosci. 2022;25:106–15.

Article  CAS  PubMed